about
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factorComplement-derived leukotactic factors in inflammatory synovial fluids of humans.Acute immunologic pulmonary alveolitis.Antileukotactic properties of tumor cells.Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarctionMaturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesisA unique complement derived chemotactic factor for tumor cells.The acute phase response of C3, C5, ceruloplasmin, and C-reactive protein induced by turpentine pleurisy in the rabbitComplement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.Experimental cytomegalovirus ophthalmitis.Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cellsAcute inflammation. A review.Leukotactic factors in health and disease.The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.Leukotactic factors elaborated by virus-infected tissues.Platelet-dependent generation of chemotactic activity in serum.Production of mononuclear cell chemotactic factors during Sindbis virus infection of mice.Polymorphonuclear leukocyte and monocyte chemoattractants produced by human fibroblastsThe inflammatory mediators.The pharmacological mediation of the acute inflammatory response: a brief review.Chemotactic activity in periodontal disease. II. The generation of complement-derived chemotactic factors.Membrane receptors on neutrophils.Isolated basal keratinocytes express pemphigoid gestationis antigen.Chemotaxis of inflammatory cells.Cellular serine proteinase induces chemotaxis by complement activation.Complement as a mediator of the inflammatory response: interaction of complement with mammalian and bacterial enzymes.
P2860
Q28303590-3AA370FE-2A32-4CFF-995F-9C7CD1F3B5A0Q34058258-ABE50A2E-259F-4236-83C5-C97C03BA5B88Q34464924-AB1793C9-C716-44D8-B48E-9ADF68A52B71Q34481379-A52E836F-08D6-4C64-ABA6-6B2953A028DEQ34482115-704A62B5-9894-4525-B5E9-3906442DB063Q34501079-EBB2AFED-80FB-453F-9173-CF94C6E4578BQ35092360-4F43704A-DE5A-4BB2-AAFD-D945D8145C23Q35835271-98AC390F-CDDE-4E3B-9EBC-725D014A9DA4Q35841134-ADFEA2DE-B287-4728-BCFF-E86EC7C82DEDQ35875615-D6C5B90A-E3EF-4DB3-8ADF-63A63577C2AAQ35878087-A8E1A3FE-3D33-432F-B7F8-D9DF932816C6Q36076876-93F3ED84-29EA-4E00-BF82-DDE71B2A377BQ36101878-18CB9581-0AC7-4AC5-819E-13B6B284C6E6Q36270882-4C7392A7-D73D-491F-8F1A-576C48ABA0BDQ36270966-98F64FE9-6F7A-4405-98EB-2947FAEDE34DQ36272285-F23F174A-F521-4540-B2F3-C19B3410757AQ36437645-AD626C2F-2145-41E7-B17C-4A35931E12D0Q37037171-F4856472-B3AA-4293-8706-2D2B112F9332Q39870275-5143F6E8-446C-47D6-851E-E9E0842B118DQ39872069-B3193C94-87F1-4669-9931-AFA749A91D85Q39883270-263CAF08-AFBB-475B-9CD6-FC77B9A89D45Q40652742-971117BA-74A6-4A93-BF99-3C84FE0EB22FQ42137310-BB5F979B-AE83-4485-B59F-60E0908B5EA9Q43862521-86EF7AC6-FCE6-4782-803A-10E34DA0A3B2Q44863408-F74269EE-2B8E-403F-B4BE-9E8D4CC0540BQ46744757-843DC7ED-31DD-45C2-B34B-5AFF7EDC8CFB
P2860
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
C3 leukotactic factors produced by a tissue protease.
@ast
C3 leukotactic factors produced by a tissue protease.
@en
type
label
C3 leukotactic factors produced by a tissue protease.
@ast
C3 leukotactic factors produced by a tissue protease.
@en
prefLabel
C3 leukotactic factors produced by a tissue protease.
@ast
C3 leukotactic factors produced by a tissue protease.
@en
P2860
P356
P1476
C3 leukotactic factors produced by a tissue protease.
@en
P2093
P2860
P304
P356
10.1084/JEM.130.3.505
P407
P577
1969-09-01T00:00:00Z